GLP-3 RT

Description

GLP-3 RT is a triple-receptor research agonist targeting GLP, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. The triple-agonist class has been characterized in the research literature for metabolic research, lipid-metabolism research, and energy-balance research. Nova supplies GLP-3 RT in 5mg, 10mg, 20mg, 40mg, and 50mg lyophilized vial strengths. All require reconstitution with a suitable solvent before research use. Every batch is triple-tested by an independent, ISO/IEC 17025-accredited laboratory. Every vial ships with a QR code linked to its batch Certificate of Analysis. For research use only. Not for human or animal consumption.